WS #1826

The most significant market-moving signal in this data dump is the escalating geopolitical crisis in the Middle East, specifically regarding the Strait of Hormuz. Multiple sources corroborate that Iran is considering imposing transit fees on vessels passing through the strait, a move that could monetize its control over this critical chokepoint where 20% of global oil flows daily. This development, reported by Reuters and echoed in social media posts, intensifies supply constraints and could drive oil prices higher, affecting energy stocks and broader indices. Concurrently, a British military planning team has been dispatched to U.S. Central Command to collaborate on strategies for reopening the strait, indicating coordinated efforts to address the blockade, which may eventually ease pressure but adds near-term uncertainty. In corporate developments, Theravance Biopharma reported Q4 EPS of $1.15, beating estimates of $1.02, a 2400% increase year-over-year, though sales missed expectations. This positive earnings surprise could boost its stock. LivaNova received FDA premarket approval for its aura6000 system for sleep apnea treatment, a bullish signal for the healthcare sector. Conversely, Intuitive Machines shares are trading lower after worse-than-expected Q4 sales, and Micron Technology shares dipped despite strong Q2 beats due to heavy capex forecasts and supply constraints, highlighting sector-specific risks. Market sentiment is further influenced by monetary policy expectations, with Bloomberg reporting that bond traders no longer price in any chance of a Fed cut in 2026, reinforcing higher-for-longer rate pressures. Additionally, aluminum prices fell more than 8% on the LME, the biggest drop since 2018, signaling potential weakness in industrial metals. These factors collectively point to heightened volatility in energy, healthcare, and technology sectors, with oil prices and interest rates as key drivers in the near term.